These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 4687786)

  • 1. Amine metabolites in human cerebrospinal fluid: effects of cord transection and spinal fluid block.
    Post RM; Goodwin FK; Gordon E; Watkin DM
    Science; 1973 Mar; 179(4076):897-9. PubMed ID: 4687786
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Spinal reflexes and the concentrations of 5-HIAA, MHPG, and HVA in lumbar cereborspinal fluid after spinal lesions in man.
    Ashby P; Verrier M; Warsh JJ; Price KS
    J Neurol Neurosurg Psychiatry; 1976 Dec; 39(12):1191-200. PubMed ID: 1011029
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Psychomotor activity and cerebrospinal fluid amine metabolites in affective illness.
    Post RM; Kotin J; Goodwin FK; Gordon EK
    Am J Psychiatry; 1973 Jan; 130(1):67-72. PubMed ID: 4682750
    [No Abstract]   [Full Text] [Related]  

  • 4. Amine metabolites in ventricular cerebrospinal fluid in coma.
    Yates CM; Tsementzis SA; Wilson H
    J Neurol Neurosurg Psychiatry; 1979 Oct; 42(10):887-91. PubMed ID: 512664
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monoamine metabolites in lumbar CSF: the question of their origin in relation to clinical studies.
    Garelis E; Young SN; Lal S; Sourkes TL
    Brain Res; 1974 Oct; 79(1):1-8. PubMed ID: 4279131
    [No Abstract]   [Full Text] [Related]  

  • 6. Effect of intravenously administered probenecid in humans on the levels of 5-hydroxyindoleacetic acid, homovanillic acid and 3-methoxy-4-hydroxy-phenylglycol in cerebrospinal fluid.
    Korf J; van Praag HM; Sebens JB
    Biochem Pharmacol; 1971 Mar; 20(3):659-68. PubMed ID: 5150161
    [No Abstract]   [Full Text] [Related]  

  • 7. Age effect on dopamine and serotonin metabolite levels in cerebrospinal fluid.
    Seifert WE; Foxx JL; Butler IJ
    Ann Neurol; 1980 Jul; 8(1):38-42. PubMed ID: 6157351
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Isocratic analysis of 3-methoxy-4-hydroxyphenyl glycol, 5-hydroxyindole-3-acetic acid and 4-hydroxy-3-methoxyphenylacetic acid in cerebrospinal fluid by high-performance liquid chromatography with amperometric detection.
    Bottiglieri T; Lim CK; Peters TJ
    J Chromatogr; 1984 Nov; 311(2):354-60. PubMed ID: 6084013
    [No Abstract]   [Full Text] [Related]  

  • 9. 5-Hydroxyindoleacetic acid and homovanillic acid in human cerebrospinal fluid below partial and complete spinal subarachnoid block.
    Massarotti M; Roccella P; Toffano G
    Eur Neurol; 1978; 17(3):174-80. PubMed ID: 658062
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Monoamine metabolites in the CSF of epileptic patients.
    Laxer KD; Sourkes TL; Fang TY; Young SN; Gauthier SG; Missala K
    Neurology; 1979 Aug; 29(8):1157-61. PubMed ID: 37460
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Monoamine metabolite concentrations in lumbar cerebrospinal fluid of patients with histologically verified Alzheimer's dementia.
    Palmer AM; Sims NR; Bowen DM; Neary D; Palo J; Wikstrom J; Davison AN
    J Neurol Neurosurg Psychiatry; 1984 May; 47(5):481-4. PubMed ID: 6204017
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stability of monoamine metabolites in human cerebrospinal fluid.
    Langlais PJ; Bird ED; McEntee WJ
    Ann Neurol; 1982 Jul; 12(1):48-51. PubMed ID: 6180677
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cerebrospinal fluid levels of MHPG in affective disorders.
    Wilk S; Shopsin B; Gershon S; Suhl M
    Nature; 1972 Feb; 235(5339):440-1. PubMed ID: 4553689
    [No Abstract]   [Full Text] [Related]  

  • 14. 5-Hydroxyindoleacetic acid and homovanillic acid in cerebrospinal fluid of patients with neurological diseases.
    Johannsson B; Roos BE
    Eur Neurol; 1974; 11(1):37-45. PubMed ID: 4363875
    [No Abstract]   [Full Text] [Related]  

  • 15. Monoamine metabolites in cerebrospinal fluid in multiple sclerosis.
    Davidson D; Pullar IA; Mawdsley C; Kinloch N; Yates CM
    J Neurol Neurosurg Psychiatry; 1977 Aug; 40(8):741-5. PubMed ID: 925693
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Concentration gradients of monoamine metabolites in human cerebrospinal fluid.
    Sjöström R; Ekstedt J; Anggård E
    J Neurol Neurosurg Psychiatry; 1975 Jul; 38(7):666-8. PubMed ID: 1159438
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 5-Hydroxyindoleacetic acid in the lumbar fluid: a specific indicator of spinal cord injury.
    Bulat M; Lacković Z; Jakupcevic M; Damjanov I
    Science; 1974 Aug; 185(4150):527-8. PubMed ID: 4841583
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Monoamine metabolites in human cerebrospinal fluid: indicators of neuronal activity?
    Scheinin M
    Med Biol; 1985; 63(1):1-17. PubMed ID: 2582215
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of probenecid on free 3-methoxy-4-hydroxyphenylethylene glycol (MHPG) and its sulphate in human cerebrospinal fluid.
    Gordon EK; Oliver J; Goodwin FK; Chase TN; Post RM
    Neuropharmacology; 1973 Apr; 12(4):391-6. PubMed ID: 4703880
    [No Abstract]   [Full Text] [Related]  

  • 20. Monoamine metabolite levels in cerebrospinal fluid and brain atrophy in lobotomized schizophrenic patients.
    Rimón R; Roos BE; Kampman R; Hyyppä S; Ranta P; Myllylä V
    Ann Clin Res; 1979 Feb; 11(1):25-9. PubMed ID: 453776
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.